RecruitingPHASE2, PHASE3NCT07535554

The Investigators Will Evaluate the Diagnostic Performance of [18F]-AlF-FAPI-74 PET/CT in Inflammatory Disorders and Compare it With the Current Gold Standard for Inflammation, FDG PET/CT, in Three Patient Cohort: Patients Presenting With Fever of Unknown Origin, IgG4-RD and AxSpA.

Studying IgG4-related disease

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Universitaire Ziekenhuizen KU Leuven
Intervention
[18F]AlF-FAPI-74 PET/CT(diagnostic_test)
Enrollment
140 enrolled
Eligibility
18 years · All sexes
Timeline
2025 – 2030

Study locations (1)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT07535554 on ClinicalTrials.gov

Other trials for IgG4-related disease

Additional recruiting or active studies for the same condition.

See all trials for IgG4-related disease →

← Back to all trials